Thymosin Alpha-1 10mg
Immune-modulating peptide for enhanced immune function
In Stock (20 available)
SKU: ML-TA1-10MG
💰 Volume Discounts:
Buy 3+ vials = 10% off · Buy 5+ vials = 15% off
Description
Thymosin Alpha-1 10mg
Thymosin Alpha-1 (Tα1) is a naturally occurring peptide produced by the thymus gland. It plays a critical role in immune system regulation and has been approved in over 30 countries.
Key Benefits
- Enhances T-cell function and maturation
- Modulates immune response (not just stimulation)
- Supports recovery from chronic infections
- Studied for hepatitis B and C treatment
- Well-established safety profile
Research Highlights
- Approved in multiple countries as Zadaxin
- Studied for cancer immunotherapy adjunct
- Research in COVID-19 treatment protocols
Consult with a healthcare professional for personalized guidance.
Research References
Neoadjuvant immunochemotherapy plus thymalfasin in locally advanced gastric cancer: a prospective clinical trial.
Clinical trial evaluating thymosin alpha-1 with immunochemotherapy for locally advanced gastric cancer.
A multipronged Tα1 reset of CD8(+) T cell cytotoxicity against breast cancer.
Demonstrates thymosin alpha-1 resets CD8+ T cell function to enhance anti-tumor immunity against breast cancer.
Aging and Thymosin Alpha-1.
Review of thymosin alpha-1's immunomodulatory effects in aging and its potential as an anti-aging agent.
Thymosin α1 Combined With 2HRZE/4HR Regimen as a Potential Treatment of Pulmonary Tuberculosis.
Evaluates thymosin alpha-1 as adjunct to standard tuberculosis treatment.
Efficacy of thymosin α1 for sepsis: a systematic review and meta-analysis of randomized controlled trials.
Systematic review of thymosin alpha-1's clinical efficacy in treating sepsis.
The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets.
Characterizes thymosin alpha-1's immunomodulatory effects on tumor cells and immune cell populations.
Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation.
Meta-analysis showing thymosin alpha-1 reduces inflammation and prevents infections in severe pancreatitis.